Stoen E, Kagihara J, Shagisultanova E, Fisher CM, et al. Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval. Breast Cancer Res Treat 2021;187:883-891.
PMID: 33625615